410 related articles for article (PubMed ID: 16225771)
1. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
[TBL] [Abstract][Full Text] [Related]
2. Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
Qiuping Z; Jie X; Youxin J; Qun W; Wei J; Chun L; Jin W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Qun L; Kejian Z; Zhimin S; Junyan L; Jinquan T
Oncogene; 2005 Jan; 24(4):573-84. PubMed ID: 15580304
[TBL] [Abstract][Full Text] [Related]
3. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.
Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T
J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584
[TBL] [Abstract][Full Text] [Related]
4. Developmental stage-specific shift in responsiveness to chemokines during human B-cell development.
Honczarenko M; Glodek AM; Swierkowski M; Na IK; Silberstein LE
Exp Hematol; 2006 Aug; 34(8):1093-100. PubMed ID: 16863916
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
[TBL] [Abstract][Full Text] [Related]
6. CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation.
Qiuping Z; Jei X; Youxin J; Wei J; Chun L; Jin W; Qun W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Kejian Z; Zhimin S; Qun L; Junyan L; Jinquan T
Cancer Res; 2004 Oct; 64(20):7579-87. PubMed ID: 15492285
[TBL] [Abstract][Full Text] [Related]
7. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.
Ebert LM; Schaerli P; Moser B
Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268
[TBL] [Abstract][Full Text] [Related]
8. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
9. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
[TBL] [Abstract][Full Text] [Related]
10. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia.
Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C
J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585
[TBL] [Abstract][Full Text] [Related]
11. CXCR5+ CCR7- CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles.
Quigley MF; Gonzalez VD; Granath A; Andersson J; Sandberg JK
Eur J Immunol; 2007 Dec; 37(12):3352-62. PubMed ID: 18000950
[TBL] [Abstract][Full Text] [Related]
12. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking.
Lipp M; Müller G
Verh Dtsch Ges Pathol; 2003; 87():90-101. PubMed ID: 16888899
[TBL] [Abstract][Full Text] [Related]
13. CXCL13 expression and follicular dendritic cells in relation to B-cell infiltration in periodontal disease tissues.
Nakajima T; Amanuma R; Ueki-Maruyama K; Oda T; Honda T; Ito H; Yamazaki K
J Periodontal Res; 2008 Dec; 43(6):635-41. PubMed ID: 18624951
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
15. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.
Schaerli P; Willimann K; Lang AB; Lipp M; Loetscher P; Moser B
J Exp Med; 2000 Dec; 192(11):1553-62. PubMed ID: 11104798
[TBL] [Abstract][Full Text] [Related]
16. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
17. CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines.
Picchio MC; Scala E; Pomponi D; Caprini E; Frontani M; Angelucci I; Mangoni A; Lazzeri C; Perez M; Remotti D; Bonoldi E; Benucci R; Baliva G; Lombardo GA; Napolitano M; Russo G; Narducci MG
Cancer Res; 2008 Sep; 68(17):7137-46. PubMed ID: 18757429
[TBL] [Abstract][Full Text] [Related]
18. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
[TBL] [Abstract][Full Text] [Related]
19. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
20. CCL19 and CXCL13 synergistically regulate interaction between B cell acute lymphocytic leukemia CD23+CD5+ B Cells and CD8+ T cells.
Wang X; Yuling H; Yanping J; Xinti T; Yaofang Y; Feng Y; Ruijin X; Li W; Lang C; Jingyi L; Zhiqing T; Jingping O; Bing X; Li Q; Chang AE; Sun Z; Youxin J; Jinquan T
J Immunol; 2007 Sep; 179(5):2880-8. PubMed ID: 17709502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
